Based on the DeepOmics™ platform developed as a global genomic data-based AI algorithm capability, we are developing systematic new antigen vaccines and anticancer drugs. After recruiting professor Paik Soon-myung, the head of Yonsei Medical Research Center, as Chief Technology Officer, we are expanding our R&D area further and aim to enter clinical trials for rectal cancer treatments and neo-antigen vaccines within 2-3 years.
We are hiring passionate and talented candidates who will fulfill their dreams and future 365 days a year.
If you apply through "Careers- Online Application," we will review it within a week and reply kindly.
Complete an online job application form or upload a resume on Theragen Bio's website